Lin M - Search Results

1

Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target.

Lin M, Li Y, Wang S, Cao B, Li C, Li G. Lin M, et al. J Oncol. 2022 Jun 28;2022:9099612. doi: 10.1155/2022/9099612. eCollection 2022. J Oncol. 2022. PMID: 35799611 Free PMC article. Review.

2

The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment.

Lin M, Xiong W, Wang S, Li Y, Hou C, Li C, Li G. Lin M, et al. Front Cardiovasc Med. 2022 Jan 12;8:821663. doi: 10.3389/fcvm.2021.821663. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35097033 Free PMC article. Review.

3

Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer.

Li Y, Lin M, Wang S, Cao B, Li C, Li G. Li Y, et al. Among authors: lin m. Front Oncol. 2022 Mar 16;12:842960. doi: 10.3389/fonc.2022.842960. eCollection 2022. Front Oncol. 2022. PMID: 35372042 Free PMC article. Review.

4

Xihuang Pill enhances anticancer effect of anlotinib by regulating gut microbiota composition and tumor angiogenesis pathway.

Cao B, Wang S, Li R, Wang Z, Li T, Zhang Y, Dong B, Li Y, Lin M, Li X, Xiao X, Li C, Li G. Cao B, et al. Among authors: lin m. Biomed Pharmacother. 2022 Jul;151:113081. doi: 10.1016/j.biopha.2022.113081. Epub 2022 May 20. Biomed Pharmacother. 2022. PMID: 35605293 Free article.

5

Analysis of interactions of immune checkpoint inhibitors with antibiotics in cancer therapy.

Li Y, Wang S, Lin M, Hou C, Li C, Li G. Li Y, et al. Among authors: lin m. Front Med. 2022 Jun;16(3):307-321. doi: 10.1007/s11684-022-0927-0. Epub 2022 Jun 1. Front Med. 2022. PMID: 35648368 Review.

6

Improving Chuanxiong Rhizoma quality standards using an effect-constituent index based bioassay.

Li C, Liu Y, Cao B, Lin M, Wang S, Dong B, Zhang M, Li G. Li C, et al. Among authors: lin m. J Pharm Biomed Anal. 2023 Sep 5;233:115455. doi: 10.1016/j.jpba.2023.115455. Epub 2023 May 13. J Pharm Biomed Anal. 2023. PMID: 37201235

7

Bavachin combined with epimedin B induce idiosyncratic liver injury under immunological stress conditions.

Lin M, Li Y, Cao B, Xu J, Zhang Y, Li G, Xiao X, Li C. Lin M, et al. Chem Biol Interact. 2023 Dec 1;386:110774. doi: 10.1016/j.cbi.2023.110774. Epub 2023 Oct 20. Chem Biol Interact. 2023. PMID: 37866487

8

[Pseudo-targeted metabolomics study of immune stress-mediated idiosyncratic liver injury induced by synergistic effects of bavachin and epimedin B].

Lin MM, Li YY, Cao B, Xu J, Xiao XH, Li GH, Li CY. Lin MM, et al. Zhongguo Zhong Yao Za Zhi. 2024 Jan;49(2):443-452. doi: 10.19540/j.cnki.cjcmm.20231008.401. Zhongguo Zhong Yao Za Zhi. 2024. PMID: 38403320 Chinese.

9

An integrative lipidomics and transcriptomics study revealing Bavachin and Icariin synergistically induce idiosyncratic liver injury.

Li Y, Cao B, Lin M, Xu J, Qi S, Wang J, Xiao X, Li G, Li C. Li Y, et al. Among authors: lin m. Immunopharmacol Immunotoxicol. 2024 Dec;46(6):924-934. doi: 10.1080/08923973.2024.2424293. Epub 2024 Nov 6. Immunopharmacol Immunotoxicol. 2024. PMID: 39505304

10

Dementia Care Research and Psychosocial Factors.

Chiu YC, Lin MH, Hsu PC, Hsu WC, Chen YC. Chiu YC, et al. Among authors: lin mh. Alzheimers Dement. 2024 Dec;20 Suppl 4:e088249. doi: 10.1002/alz.088249. Alzheimers Dement. 2024. PMID: 39782087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,920 results

Search Page

Filters